These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 22099934)
1. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor. Salama A; Kamel A J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934 [TBL] [Abstract][Full Text] [Related]
2. Clinical and biologic significance of nuclear unrest in Wilms tumor. Hill DA; Shear TD; Liu T; Billups CA; Singh PK; Dome JS Cancer; 2003 May; 97(9):2318-26. PubMed ID: 12712489 [TBL] [Abstract][Full Text] [Related]
3. Anaplastic histology Wilms' tumors registered to the Japan Wilms' Tumor Study Group are less aggressive than that in the National Wilms' Tumor Study 5. Oue T; Koshinaga T; Takimoto T; Okita H; Tanaka Y; Nozaki M; Haruta M; Kaneko Y; Fukuzawa M; Pediatr Surg Int; 2016 Sep; 32(9):851-5. PubMed ID: 27473009 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia. Cheah PL; Looi LM; Chan LL Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120 [TBL] [Abstract][Full Text] [Related]
5. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034 [TBL] [Abstract][Full Text] [Related]
6. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors. Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of Wilms' tumor in eastern China: 10 years of experience at a single center. Yao W; Li K; Xiao X; Gao J; Dong K; Xiao X; Lv Z J Invest Surg; 2012 Jun; 25(3):181-5. PubMed ID: 22583015 [TBL] [Abstract][Full Text] [Related]
8. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Weirich A; Ludwig R; Graf N; Abel U; Leuschner I; Vujanic GM; Mehls O; Boos J; Beck J; Royer-Pokora B; Voûte PA Ann Oncol; 2004 May; 15(5):808-20. PubMed ID: 15111352 [TBL] [Abstract][Full Text] [Related]
9. Management and outcome of pediatric metastatic Wilms' tumor at the National Cancer Institute, Egypt. Elayadi M; Magdy S; Khalil E; Zekri W J Egypt Natl Canc Inst; 2020 Apr; 32(1):19. PubMed ID: 32372204 [TBL] [Abstract][Full Text] [Related]
10. Wilms' tumor: the experience of the pediatric unit of Kasr El-Aini center of radiation oncology and nuclear medicine (NEMROCK). Abd El-Aal HH; Habib EE; Mishrif MM J Egypt Natl Canc Inst; 2005 Dec; 17(4):308-14. PubMed ID: 17102824 [TBL] [Abstract][Full Text] [Related]
11. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group. Green DM; Beckwith JB; Breslow NE; Faria P; Moksness J; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S J Clin Oncol; 1994 Oct; 12(10):2126-31. PubMed ID: 7931483 [TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan. Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of p53 expression in Wilms' tumor in children. Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734 [TBL] [Abstract][Full Text] [Related]
14. Anaplasia in unilateral Wilms' tumor: a report from the National Wilms' Tumor Study Pathology Center. Zuppan CW; Beckwith JB; Luckey DW Hum Pathol; 1988 Oct; 19(10):1199-209. PubMed ID: 2844645 [TBL] [Abstract][Full Text] [Related]
15. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor. Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318 [TBL] [Abstract][Full Text] [Related]
16. p53 expression in Wilms' tumor: a possible role as prognostic factor. Beniers AJ; Efferth T; Füzesi L; Granzen B; Mertens R; Jakse G Int J Oncol; 2001 Jan; 18(1):133-9. PubMed ID: 11115550 [TBL] [Abstract][Full Text] [Related]
17. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa. Aronson DC; Hadley GP Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor. Jadali F; Sayadpour D; Rakhshan M; Karimi A; Rouzrokh M; Shamsian BS; Shamshiri AR Iran J Kidney Dis; 2011 Jul; 5(3):149-53. PubMed ID: 21525573 [TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of preoperatively treated patients with anaplastic Wilms tumors registered in the UK SIOP-WT-2001 and IMPORT study cohorts (2002-2020). Vujanić GM; Mifsud W; Chowdhury T; Al-Saadi R; Pritchard-Jones K; Cancer; 2022 Apr; 128(8):1666-1675. PubMed ID: 35119702 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Bcl-2 in Wilms' tumor and oncogenic potential of Bcl-X(L) in rare tumor cases. Re GG; Hazen-Martin DJ; El Bahtimi R; Brownlee NA; Willingham MC; Garvin AJ Int J Cancer; 1999 Apr; 84(2):192-200. PubMed ID: 10096254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]